XML 59 R30.htm IDEA: XBRL DOCUMENT v3.20.1
Equity Incentive Plan (Tables)
3 Months Ended
Mar. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of stock option activity

 

 

 

 

 

 

 

 

 

 

 

 

Options Outstanding

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

Average

 

Aggregate

 

 

 

Weighted-

 

Remaining

 

Intrinsic

 

 

Number

Average

 

Contractual

 

Value

 

    

of Shares

Exercise Price

 

Life (years)

 

(in thousands)

Balances, December 31, 2019

 

3,742,144

$

9.58

 

8.6

 

$

22,910

Granted*

 

636,000

 

22.02

 

 

 

 

 

Exercised

 

(86,872)

 

4.82

 

 

 

 

 

Cancelled

 

(6,690)

 

11.43

 

 

 

 

 

Balances, March 31, 2020

 

4,284,582

$

11.52

 

8.6

 

$

25,368

Vested and expected to vest at March 31, 2020

 

4,284,582

$

11.52

 

8.6

 

$

25,368

Exerciseable at March 31, 2020

 

1,888,288

$

6.65

 

7.8

 

$

18,813

Vested at March 31, 2020

 

1,374,666

$

7.21

 

7.7

 

$

12,954

  *  The board of directors of the Company approved the grant of 564,800 stock options on February 26, 2020. As the Company prioritized other communications including COVID-19 related matters, the terms of the 564,800 stock options were not communicated until April 2020. As a result, the Company excluded these options from the computation of expense and option activity in the quarter ended March 31, 2020. These options will be included in the second Quarterly Report on Form 10-Q.

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

 

 

 

 

 

 

 

 

Three Months Ended March 31, 

 

 

 

2020

    

2019

 

Expected life (in years)

 

5.95

 

6.02

 

Volatility

 

84.9

%  

80.8

%

Risk-free interest rate

 

1.19

%  

2.46

%

 

Schedule of stock-based compensation expense

The compensation expense is allocated on a departmental basis, based on the classification of the option holder as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31, 

 

 

    

2020

    

2019

 

Research and development

 

$

1,058

 

$

419

 

General and administrative

 

 

1,424

 

 

357

 

 

 

$

2,482

 

$

776

 

 

2019 Employee Stock Purchase Plan  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

 

 

 

 

 

 

Three Months Ended March 31, 

 

 

 

2020

    

Expected life (in years)

 

0.5 - 2.0

 

Volatility

 

91.4 - 106.8

%  

Risk-free interest rate

 

0.86 -  1.11

%